<DOC>
	<DOC>NCT02983019</DOC>
	<brief_summary>This study evaluates the statistics of influenza and acute respiratory viral infections (ARVI) management in outpatient sites in Russia, Armenia, Moldova and Georgia (epidemiology: disease severity and bacterial exacerbations; patients demography; treatment duration and timelines; safety; quality of treatment) in routine clinical practice with focus on drug therapy and usage of interferons' inducers.</brief_summary>
	<brief_title>Treatment of Influenza in Routine Clinical Practice</brief_title>
	<detailed_description>This non-interventional study covers more than 15000 patients from outpatient sites in Russia, Armenia, Moldova and Georgia. Influenza and acute respiratory viral infections (ARVI) diagnosis validate according to "World Health Organization (WHO) Guidelines for Pharmacological Management of Pandemic Influenza A (H1N1) 2009 and other Influenza Viruses". All patients' examinations are carried out according to the local routine clinical practice and local and international standards of care. The following data will be collected and analyzed after the end of treatment: - demography - disease severity - body temperature - chills and fever (no/mild/severe) - weakness (no/mild/severe) - muscle or joint pain (no/mild/severe) - rhinitis (yes/no) - throat irritation (no/mild/severe) - headache (no/mild/severe) - cough (no/mild/severe) - conjunctivitis (no/mild/severe) - timelines: disease onset, first visit to physician, start of treatment - therapy (drug name, dose, with focus on interferons' inducers) - bacterial exacerbations (yes/no) - therapy of bacterial exacerbations (drug name) - adverse events - results of treatment satisfaction questionnaire for medication (TSQM-9), if completed by patient</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon Inducers</mesh_term>
	<criteria>patients â‰¥ 18 years old, patients diagnosed with influenza or influenzalike illness caused by a different type of virus, patients to whom antiflu treatment administered, patients who have signed informed consent for management of their personal data. no exclusion criteria except participating in a current clinical trial because of noninterventional sudy design</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>influenza</keyword>
	<keyword>flu</keyword>
	<keyword>acute respiratory viral infection</keyword>
	<keyword>ARVI</keyword>
	<keyword>acute upper respiratory infection</keyword>
	<keyword>AURI</keyword>
</DOC>